Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Almujtama Alraida Medical CoSAU:9592 13 Buyback Yield % is 0.00 as of Aug. 19, 2026. GuruFocus rates SAU:9592 with a GF Score™ of 13/100. The stock has 4 warning signs investors should review. Among 260 Healthcare Providers & Services companies, Almujtama Alraida Medical Co ranks worse than 384615% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Almujtama Alraida Medical Co Buyback Yield % Chart
Almujtama Alraida Medical Co Buyback Yield % Competitor Comparison
For the Pharmaceutical Retailers subindustry, Almujtama Alraida Medical Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Almujtama Alraida Medical Co Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Almujtama Alraida Medical Co's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Almujtama Alraida Medical Co's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Almujtama Alraida Medical Co (SAU:9592) has a Buyback Yield % of 0.00 as of Aug. 19, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Almujtama Alraida Medical Co and its competitors. According to the industry distribution chart, Almujtama Alraida Medical Co ranks #999999 out of 260 companies in the Healthcare Providers & Services industry.
Is Almujtama Alraida Medical Co's Buyback Yield % too high?
Almujtama Alraida Medical Co's current Buyback Yield % is 0.00. Based on the distribution chart, Almujtama Alraida Medical Co ranks #999999 out of 260 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Almujtama Alraida Medical Co has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does Almujtama Alraida Medical Co's Buyback Yield % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Almujtama Alraida Medical Co ranks #999999 out of 260 companies for Buyback Yield %. This places Almujtama Alraida Medical Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Almujtama Alraida Medical Co and its competitors. Almujtama Alraida Medical Co's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Almujtama Alraida Medical Co stock overvalued right now?
Almujtama Alraida Medical Co (SAU:9592) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. Almujtama Alraida Medical Co's overall GF Score™ is 13/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Almujtama Alraida Medical Co (SAU:9592), the current Buyback Yield % is 0.00 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Almujtama Alraida Medical Co is a company having its core operations include operating pharmacies and retailing pharmaceutical products such as medicines and cosmetic products and medical equipment and medical supplies. It also provides pharmaceutical services in the Kingdom of Saudi Arabia.
13GF Score
Get the complete analysis for SAU:9592
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:9592 has been successfully added to your 
